Prostate cancer gene therapy.

Journal Article (Journal Article;Review)

Numerous gene therapy trials in the United States and throughout the world using various strategies are in progress for the treatment of locally advanced and metastatic prostate cancer. Although vector technology advances at a rapid pace, progress in elucidating the molecular pathways critical for the development and progression of prostate cancer has been slower and more deliberate. Thus far, prostate gene therapy appears to be safe and well tolerated. Through these early clinical trials, the safety and efficacy of gene therapy alone or in combination with more conventional therapy as a basis for the treatment of prostate cancer will ultimately be determined.

Full Text

Duke Authors

Cited Authors

  • Steiner, MS; Gingrich, JR; Chauhan, RD

Published Date

  • July 2002

Published In

Volume / Issue

  • 11 / 3

Start / End Page

  • 607 - 620

PubMed ID

  • 12487058

International Standard Serial Number (ISSN)

  • 1055-3207

Digital Object Identifier (DOI)

  • 10.1016/s1055-3207(02)00026-1


  • eng

Conference Location

  • United States